Silence Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLN and other ETFs, options, and stocks.

About SLN

Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. 

CEO
Craig Allen Tooman
CEOCraig Allen Tooman
Employees
Employees
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
1994
Founded1994
Employees
Employees

SLN Key Statistics

Market cap
367.14M
Market cap367.14M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
41.10K
Average volume41.10K
High today
$10.23
High today$10.23
Low today
$9.57
Low today$9.57
Open price
$9.69
Open price$9.69
Volume
36.26K
Volume36.26K
52 Week high
$26.84
52 Week high$26.84
52 Week low
$7.80
52 Week low$7.80

SLN Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
per share
Estimated per share
Actual
Actual
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.